Cancer screening in a middle-income country: the idealist versus the pragmatist

Event Details


CAN Mezzanine, 7-14 Great Dover Street London, SE1 4YR, United Kingdom

View Map


Start: Thursday, 28 November 2019 @ 8:30 a.m. (breakfast & registration from 8am)

End: Thursday, 28 November 2019 @ 10am

C3 is delighted to welcome Dr Feisul Mustapha, Consultant Public Health Physician and Deputy Director (NCDs) at the Ministry of Health Malaysia, to speak at a special International Breakfast Seminar on Cancer Prevention as part of London Global Cancer Week on Thursday, 28 November 2019

Like most developed and developing countries, Malaysia is experiencing an epidemiological transition where Non-Communicable Diseases (NCDs) in particular cardiovascular diseases and cancers have progressively become more prevalent.

In cancer, early detection and prompt treatment improves the chances of cure. Unfortunately, delays in presentation are commonly found among our cancer patients. Almost 60 per cent of cancers in Malaysia are detected late (stage III and IV) despite the availability and accessibility of cancer screening.

Although the core concepts of cancer prevention and control programmes should be applied universally, implementation of screening programs in a middle-income country such as Malaysia require distinct considerations. It must be an iterative process with realistic interventions taking into consideration cultural values and belief systems, beyond healthcare systems.

Working in a resource-constrained setting, yet with the involvement of various stakeholders and players, Malaysia is moving forward and will continue to engage new partners for potential collaborative work to address the various challenges.

Booking ended

About the speaker:

Dr. Feisul Mustapha is a public health physician best known for his leadership in prevention and control of non-communicable diseases (NCDs) in Malaysia. His special areas of interest include diabetes, cardiovascular diseases, cancer and obesity. At the Ministry of Health Malaysia (MOH), his main roles include policy and programme development, and strategic implementation of interventions for the prevention and control of NCDs. In addition, Dr Feisul has a special interest in leveraging on technology in catalysing behavioural modification to reduce the exposure to NCD risk factors.

He combines his high-level experiences in the government with active engagement of civil society and multilateral institutions. He was a member of the WHO Ad-hoc Working Group on Implementation, Monitoring and Accountability on the Commission on Ending Childhood Obesity, 2015-2017. He is a member of the Policy Advisory Group of the World Cancer Research Fund International (WCRF), 2017-2019, and is currently Chair of the Scientific Advisory Group for the Monash University South East Asia Community Observatory, 2019-2021.


C3’s 2019 International Breakfast Seminar series is supported by:

Cancer Research UK logo The College of Contemporary Health logo Sanofi logo   Wellbeing People logo